Last November, the Treasury launched the Patient Capital Review.
Its aim was to identify the barriers that innovative companies may face in gaining access to long term, supportive finance.
It is being overseen by an A list of entrepreneurs and investment experts, chaired by former Permira head Sir Damon Buffini, who are supremely well-qualified to define the issue and recommend solutions.
